Endologix’ Nellix receives CE mark with refined Instructions for Use

Endologix has been granted CE mark approval for its Nellix endovascular aneurysm sealing system, with refined Instructions for Use (IFU). Nellix is being studied...

InGeneron announces positive results from wound healing case series using regenerative cell technology

InGeneron has announced the publication of results from an investigator initiated case series in chronic leg wounds in the Journal of the European Academy...

Aplagon partners with Cadila Pharmaceuticals to develop and commercialise antithrombotics

Aplagon and Cadila Pharmaceuticals Sweden AB have announced a development and commercialisation agreement for Aplagon’s lead APAC product. APACs are proprietary, locally acting, potent antithrombotic...

Data from multiple studies support concept of low metal burden therapies in the superficial...

Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates, according to results from various Biotronik studies...

Maarit Venermo

R Clement Darling III

Vincent Riambau